: Confirmation that a primary source (e.g., doctor, patient) exists.
: Clear identification of the substance or medicinal product involved.
This "detailed guide" is part of a broader set of that govern pharmacovigilance in the EU. It is specifically tied to Module VI , which handles the collection, management, and submission of reports for suspected adverse reactions. major_spz_x_dwie_belki_gwiazdka_konopie_prod_at...
This guide is designed for to ensure they correctly identify and report Individual Case Safety Reports (ICSRs) found in medical literature. Key Components of the Guidance
The phrase appears to be a specific, internal file or code name associated with the European Medicines Agency (EMA) and its Good Pharmacovigilance Practices (GVP) . Specifically, this string is found in the metadata of the detailed guide regarding monitoring medical literature , which outlines the entry of relevant information into the EudraVigilance database. Purpose of the Guide : Confirmation that a primary source (e
: Specific details like gender or age must be present.
: Formatting requirements for recording information in the EudraVigilance database, including author names and journal details in Vancouver style . Regulatory Context It is specifically tied to Module VI ,
: Guidance on how the EMA monitors literature for certain active substances, reducing the duplicative workload for MAHs.